Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Reply July 10 2024
Response to: 'In Response to, "Preferences for potential benefits and risks for gene therapy..."'
Research Article July 10 2024
CD19-directed CART Therapy for T cell/Histiocyte Rich Large B-cell Lymphoma
Research Article July 5 2024
Nilotinib vs. Dasatinib in Achieving MR4.5 for de novo Chronic Myeloid Leukemia: the Randomized JALSG CML212 Study
Research Article July 5 2024
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2 & PRN473 reduces venous thrombosis formation in mice.
Research Article July 5 2024
Atrial Arrhythmia in Sickle Cell Anemia Adults: A missing link towards understanding and preventing strokes
Research Article June 28 2024
Serglycin controls megakaryocyte retention of platelet factor 4 and influences megakaryocyte fate in bone marrow
Reply June 12 2024
In Response to, "Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell disease"
Research Article June 11 2024
CNS Bridging Radiotherapy Achieves Rapid Cytoreduction Prior to CAR T Cell Therapy for Aggressive B-Cell Lymphoma
Review Article June 6 2024
Optimizing Liver Health Before and After Gene Therapy for Hemophilia A
Research Article June 3 2024
Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes
Research Article May 30 2024
Impact of an Individualized Pain Plan to Treat Sickle Cell Disease Vaso-occlusive Episodes in the Emergency Department
Research Article April 19 2024
Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data
Letter March 27 2024
Ancestral β-globin gene haplotypes modify β-thalassemia severity in a mouse model
Page 3 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals